-
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
05 May 2025 09:20 GMT
… a first-in-class genetic cure for debilitating diseases … derive benefit from Mammoth Biosciences’ genetic medicines.”
Dr. Bob D. … early clinical development of numerous genetic medicines, including nedosiran for … more than 85 issued US patents, and earned a Ph …
-
The Chickens and the Eggs
06 May 2025 13:50 GMT
… large firms often own the genetic patents on the birds, as well …
-
Metabolic Comorbidities Among Relatives of Type 2 Diabetes Patients Stratified by Weight: Implications for Prevention and Care
09 May 2025 10:21 GMT
Introduction
Diabetes is a public health problem affecting young adults, with an estimated national prevalence in Mexico of 18.3%.1 Obesity, is not only a risk factor for T2DM but is also associated with arrange of other diseases, including hypertension, …
-
THANARA: A Microbiome-Based Skincare Innovation Featuring 4P-Biotics Technology by AL-DNA
09 May 2025 03:41 GMT
… expertise in microbiology and portable genetic testing, Assoc. Prof. Dr. Naraporn … launched two skincare products, both patented and FDA-certified to ensure …
-
China Issues the 2025 Intellectual Property Nation Building Promotion Plan To Accelerate the Construction of a Powerful Intellectual Property Country
09 May 2025 01:08 GMT
… Management of Access to Biological Genetic Resources and Benefit Sharing. (The … the Regulations on National Defense Patents. (Equipment Development Department of the … )
64. Vigorously cultivate and develop patent-intensive industries and copyright industries …
-
Rocket Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Progress
08 May 2025 20:15 GMT
… a sustainable pipeline of genetic therapies for rare disorders … sustainable pipeline of investigational genetic therapies designed to correct … I), a severe pediatric genetic disorder that causes recurrent … to obtain and enforce patents to protect its product …
-
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025
08 May 2025 20:01 GMT
… allowed U.S. and international patents and patent rights for Amtagvi … covering TIL products produced with genetic engineering, using core biopsies and …
-
Pacira BioSciences Reports First Quarter 2025 Financial Results
08 May 2025 20:00 GMT
… “Orange Book”) and additional patents are forthcoming. The ‘468 … , local delivery platform for genetic medicines, a preclinical portfolio, … compared to AAV vectors.
Genetic medicines based on the … basis for locally administered genetic therapies using the HCAd …
-
Xoted Biotechnology Labs Holds Soft Launch at Spartanburg Community College’s Spark Center
08 May 2025 20:00 GMT
… . “With additional high-value patents in the pipeline, the initiative … seven U.S. patents, 11 patents pending, 78 patents to be filed, … & energy innovation.
These patents, valued at over $1 billion … on a tree to the genetic code within ourselves. That …
-
Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025
08 May 2025 20:05 GMT
… develop plant traits (or specific genetic characteristics) in seeds, today announced … biology team to identify novel genetic targets for disease resistance in … specific application of Cibus' patented Rapid Trait Development System™ (RTDS …